Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Gac Med Mex ; 155(4): 428-435, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31486801

RESUMO

Neuropathic pain is an entity that causes patient disability and its diagnosis and treatment is a challenge for physicians. In a significant percentage of patients with neuropathic pain, it is restricted to one dermatome or to a particular region of the body; in this case, it is referred to as localized neuropathic pain. There are no Mexican clinical guidelines proposing recommendations for the diagnosis and treatment of localized neuropathic pain in our population. This article presents the recommendations of a multidisciplinary consensus of specialists from different areas involved in the diagnosis and treatment of this type of patients.


El dolor neuropático es una entidad que provoca discapacidad al paciente y su diagnóstico y tratamiento es un reto para los médicos. En un porcentaje importante de pacientes afectados, el dolor neuropático se presenta circunscrito a un dermatoma o a una región concreta del cuerpo, denominándose en ese caso dolor neuropático localizado. No existen guías clínicas mexicanas que postulen recomendaciones para el diagnóstico y tratamiento del dolor neuropático localizado en nuestra población. En este artículo se exponen las recomendaciones de un consenso multidisciplinario realizado con especialistas de distintas áreas implicadas en el diagnóstico y tratamiento de este tipo de pacientes.


Assuntos
Neuralgia/diagnóstico , Doenças do Sistema Nervoso Periférico/diagnóstico , Humanos , México , Neuralgia/terapia , Doenças do Sistema Nervoso Periférico/terapia
2.
Gac. méd. Méx ; 155(4): 428-435, jul.-ago. 2019. graf
Artigo em Inglês, Espanhol | LILACS | ID: biblio-1286529

RESUMO

Resumen El dolor neuropático es una entidad que provoca discapacidad al paciente y su diagnóstico y tratamiento es un reto para los médicos. En un porcentaje importante de pacientes afectados, el dolor neuropático se presenta circunscrito a un dermatoma o a una región concreta del cuerpo, denominándose en ese caso dolor neuropático localizado. No existen guías clínicas mexicanas que postulen recomendaciones para el diagnóstico y tratamiento del dolor neuropático localizado en nuestra población. En este artículo se exponen las recomendaciones de un consenso multidisciplinario realizado con especialistas de distintas áreas implicadas en el diagnóstico y tratamiento de este tipo de pacientes.


Abstract Neuropathic pain is an entity that causes patient disability and its diagnosis and treatment is a challenge for physicians. In a significant percentage of patients with neuropathic pain, it is restricted to one dermatome or to a particular region of the body; in this case, it is referred to as localized neuropathic pain. There are no Mexican clinical guidelines proposing recommendations for the diagnosis and treatment of localized neuropathic pain in our population. This article presents the recommendations of a multidisciplinary consensus of specialists from different areas involved in the diagnosis and treatment of this type of patients.


Assuntos
Humanos , Doenças do Sistema Nervoso Periférico/diagnóstico , Neuralgia/diagnóstico , Doenças do Sistema Nervoso Periférico/terapia , México , Neuralgia/terapia
3.
Pain Manag ; 7(3): 207-215, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28166710

RESUMO

AIM: Latin-American experts in the use of opioids in patients with chronic nononcologic pain (CNOP) have updated existing recommendations to current Latin-American reality. METHODS: Several key opinion leaders from Latin America participated in a face-to-face meeting in Guatemala (April 2015) to discuss the use of opioids in CNOP. Subgroups of experts worked on specific topics, reviewed the literature and shaped the final manuscript. RESULTS: The expert panel developed guidelines taking into consideration the utility of both opioid and nonopioid analgesics and factors pertaining to their efficacy, safety, adherence, administration and risks for abuse/addiction. CONCLUSION: Latin-American guidelines for the use of opioids in CNOP should improve pain relief and patients' quality of life by increasing access to these effective agents.


Assuntos
Analgésicos Opioides/uso terapêutico , Dor Crônica/tratamento farmacológico , Manejo da Dor , Qualidade de Vida , Analgésicos Opioides/efeitos adversos , Humanos , América Latina , Adesão à Medicação , Transtornos Relacionados ao Uso de Opioides/prevenção & controle , Resultado do Tratamento
4.
Cir Cir ; 73(5): 393-404, 2005.
Artigo em Espanhol | MEDLINE | ID: mdl-16336806

RESUMO

Acute pain is a frequent entity in the hospital setting and the complexity of its management results in the necessity for practice guidelines to assist health care personnel in decision making for treatment of pain. In Mexico, as in other countries, different task forces have provided recommendations in order to achieve this goal. The present report presents the results obtained by a multidisciplinary group who explored the actual state of acute pain in the country using a questionnaire. Meanwhile, they also analyzed the scientific evidence contained in the literature. The results of these efforts are contained in the practice guidelines proposed by this task force.


Assuntos
Manejo da Dor , Doença Aguda , Analgesia/métodos , Analgésicos , Árvores de Decisões , Medicina Baseada em Evidências , Humanos , Dor/tratamento farmacológico
5.
Cir Cir ; 73(3): 223-32, 2005.
Artigo em Espanhol | MEDLINE | ID: mdl-16091164

RESUMO

The inadequacy of perioperative management causes a severe adverse outcome, a prolonged time of hospitalization and unnecessary suffering. Therefore, it is important to provide an effective management approach to the patient with perioperative pain. A task force with experience in this field systematically develops practice guidelines and the primary goal is to facilitate, to health care professionals, decision-making regarding pain relief. The well-known concept of "administer as needed" is inaccurate and must be eliminated from hospital's management protocols in order to facilitate the staff education to decrease the painful experience. A method to evaluate and document pain in an objective and periodic way shall be implemented. Also, analgesic therapy shall be individualized and chosen regarding pain intensity in every surgical procedure. The treatment options include the use of non-opiate and opiate drugs, regional analgesia and nonpharmacological techniques. The best analgesic will be the one that shall provide the highest relief of pain with the fewest side effects. In the pediatric and obstetric populations, special considerations for the ambulatory patient must be taken. Finally, these practice guidelines could be the reference for future practice guidelines on pain management in Mexico.


Assuntos
Analgesia/métodos , Analgésicos/uso terapêutico , Complicações Intraoperatórias , Dor Pós-Operatória/tratamento farmacológico , Doença Aguda , Adulto , Analgesia Obstétrica/métodos , Analgésicos/administração & dosagem , Analgésicos não Narcóticos/administração & dosagem , Analgésicos não Narcóticos/uso terapêutico , Analgésicos Opioides/administração & dosagem , Analgésicos Opioides/uso terapêutico , Criança , Pré-Escolar , Feminino , Previsões , Humanos , Lactente , Complicações Intraoperatórias/tratamento farmacológico , Masculino , México , Pacientes Ambulatoriais , Medição da Dor , Guias de Prática Clínica como Assunto , Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...